Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Work Medical Technology Group Inc. (WOK) Stock Forecast & Price Prediction China | NASDAQ | Healthcare | Medical Devices
$0.76
-0.01 (-1.56%)Did WOK Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if WORK Medical is one of their latest high-conviction picks.
Comprehensive analyst forecasts are currently unavailable for WOK. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for WOK.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to WORK Medical based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Work Medical Technology Group Inc. has a market capitalization of $24.38M with a P/E ratio of 0.0x. The company generates $11.51M in trailing twelve-month revenue with a -30.4% profit margin.
Revenue growth is +36.1% quarter-over-quarter, while maintaining an operating margin of -57.1% and return on equity of -26.2%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops advanced medical devices and solutions.
The company generates revenue by innovating and providing cutting-edge medical devices and solutions to healthcare professionals. Its diverse product portfolio includes imaging systems, diagnostic machines, and surgical equipment that cater to various medical disciplines, thereby enhancing patient care and supporting healthcare providers in diagnostics and treatment.
Work Medical Technology Group Inc. is positioned to capitalize on trends in increasing healthcare spending and technological advancements, making it a compelling option for investors seeking exposure to the healthcare and technology sectors. Its contributions to hospitals, clinics, and research institutions are significant in improving global healthcare standards.
Healthcare
Medical Devices
216
Mr. Shuang Wu
China
N/A
WORK Medical Technology Group Ltd. priced a registered offering of 10 million ordinary units at $0.50 each and pre-funded units at $0.4995 each, through its subsidiary in China.
WORK Medical's offering of 10 million units at low prices signals potential dilution of existing shares, impacting stock value and investor sentiment.
WORK Medical Technology Group LTD closed a registered offering of 10 million ordinary units at $0.50 each, raising funds for its operations in China.
WORK Medical's $5 million capital raise through a registered offering may impact liquidity, funding for growth, and investor sentiment, influencing stock performance and market perception.
Univest Securities has closed a registered offering for WORK Medical Technology Group LTD (Nasdaq: WOK), a supplier of medical devices in China, through its subsidiary.
The closure of the offering by WORK Medical Technology Group can indicate increased capital for growth, influencing stock performance and investor sentiment in the medical device sector.
WORK Medical Technology Group (Nasdaq: WOK) has received a notification from Nasdaq regarding non-compliance with minimum bid price requirements for continued listing.
WORK Medical's non-compliance with Nasdaq's minimum bid price requirement raises concerns about its financial health and may lead to delisting, impacting investor confidence and stock value.
WORK Medical Technology Group LTD (Nasdaq: WOK) will implement a dual-class share structure effective March 6, 2025, through its subsidiary in China.
The dual-class share structure may affect voting power and control within WORK Medical, potentially impacting strategic decisions and investor influence.
WORK Medical Technology Group LTD has formed a strategic partnership with Shanghai Chartwell Medical Device Co., enhancing its medical device offerings in China.
WORK Medical's strategic partnership with Shanghai Chartwell could enhance its market position and product offerings, potentially leading to revenue growth and increased investor confidence.
Analyst forecasts for Work Medical Technology Group Inc. (WOK) are not currently available. The stock is trading at $0.76.
Analyst ratings for WOK are not currently available. The stock is currently trading at $0.76. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
Price predictions from Wall Street analysts for WOK are not currently available. The stock is trading at $0.76.
The company generates revenue by innovating and providing cutting-edge medical devices and solutions to healthcare professionals. Its diverse product portfolio includes imaging systems, diagnostic machines, and surgical equipment that cater to various medical disciplines, thereby enhancing patient care and supporting healthcare providers in diagnostics and treatment.
Price targets from Wall Street analysts for WOK are not currently available. The stock is trading at $0.76.
Price targets from Wall Street analysts for WOK are not currently available. The stock is trading at $0.76.
Analyst ratings for WOK are not currently available. The stock is trading at $0.76.
Stock price projections, including those for Work Medical Technology Group Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.